Crystal Cruz

662 total citations
8 papers, 272 citations indexed

About

Crystal Cruz is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Crystal Cruz has authored 8 papers receiving a total of 272 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 5 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Crystal Cruz's work include Immunotherapy and Immune Responses (6 papers), vaccines and immunoinformatics approaches (5 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Crystal Cruz is often cited by papers focused on Immunotherapy and Immune Responses (6 papers), vaccines and immunoinformatics approaches (5 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Crystal Cruz collaborates with scholars based in United States and Italy. Crystal Cruz's co-authors include Sylvia Adams, Linda Pan, Anna C. Pavlick, Achim A. Jungbluth, Juliet Escalon, Ralph Venhaus, David O’Neill, Lloyd J. Old, Nina Bhardwaj and Gregory Mears and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

In The Last Decade

Crystal Cruz

8 papers receiving 267 citations

Peers

Crystal Cruz

IMMUN

ONCOL

MB

RNMI

GENET

Robyn P. Seipp Canada

Jeanette M. Pots Netherlands

Jenifer Widger United States

Iva Zlatareva United Kingdom

Juliet Escalon United States

Anita Kant United States

Gabriel R. Starbeck-Miller United States

Thomas Mørch Frøsig Denmark

Ingrid Leal Rojas Australia

R. Andres Parra Sperberg United States

Robyn P. Seipp Canada

Crystal Cruz

232 ×1.0

IMMUN

127 ×1.1

ONCOL

182 ×1.7

MB

18 ×0.9

RNMI

14 ×0.9

GENET

Citations per year, relative to Crystal Cruz Crystal Cruz (= 1×) peers Robyn P. Seipp

Countries citing papers authored by Crystal Cruz

Since Specialization

Citations

This map shows the geographic impact of Crystal Cruz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Crystal Cruz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Crystal Cruz more than expected).

Fields of papers citing papers by Crystal Cruz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Crystal Cruz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Crystal Cruz. The network helps show where Crystal Cruz may publish in the future.

Co-authorship network of co-authors of Crystal Cruz

This figure shows the co-authorship network connecting the top 25 collaborators of Crystal Cruz. A scholar is included among the top collaborators of Crystal Cruz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Crystal Cruz. Crystal Cruz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Sabado, Rachel Lubong, et al.. (2014). MAGE-specific T cells detected directly ex-vivo correlate with complete remission in metastatic breast cancer patients after sequential immune-endocrine therapy. Journal for ImmunoTherapy of Cancer. 2(1). 32–32. 7 indexed citations

2.

Sabado, Rachel Lubong, Anna C. Pavlick, Sacha Gnjatic, et al.. (2014). Phase I/II study of resiquimod as an immunologic adjuvant for NY-ESO-1 protein vaccination in patients with melanoma.. Journal of Clinical Oncology. 32(15_suppl). 9086–9086. 2 indexed citations

3.

Sabado, Rachel Lubong, Anna C. Pavlick, Sacha Gnjatic, et al.. (2013). Phase I/II study of Resiquimod as an immunologic adjuvant for NY-ESO-1 protein vaccination in patients with melanoma. Journal for ImmunoTherapy of Cancer. 1(S1). 4 indexed citations

4.

Sabado, Rachel Lubong, Anna C. Pavlick, Sacha Gnjatic, et al.. (2012). Phase I/II study of resiquimod as an immunologic adjuvant for NY-ESO-1 protein vaccination in patients with melanoma.. Journal of Clinical Oncology. 30(15_suppl). 2589–2589. 5 indexed citations

5.

Diefenbach, Catherine, Rachel Lubong Sabado, Sean Clark-Garvey, et al.. (2011). PD-1 Is Elevated on the Peripheral Blood T Cell Subsets of Patients with Relapsed/Refractory Hodgkin Lymphoma Compared to Normal Volunteers. Blood. 118(21). 4860–4860. 1 indexed citations

6.

Diefenbach, Catherine, Rachel Lubong Sabado, Christopher Brooks, et al.. (2011). Hodgkin's Lymphoma Cell Lines Have up-Regulated IL-3 Receptor α (IL-3Rα) Expression and Are Sensitive to SL-401, An IL-3Rα Targeted Drug,. Blood. 118(21). 3737–3737. 3 indexed citations

7.

O’Neill, David, Sylvia Adams, Judith D. Goldberg, et al.. (2009). Comparison of the immunogenicity of Montanide ISA 51 adjuvant and cytokine-matured dendritic cells in a randomized controlled clinical trial of melanoma vaccines. Journal of Clinical Oncology. 27(15_suppl). 3002–3002. 7 indexed citations

8.

Valmori, Danila, Naira E. Souleimanian, Valeria Tosello, et al.. (2007). Vaccination with NY-ESO-1 protein and CpG in Montanide induces integrated antibody/Th1 responses and CD8 T cells through cross-priming. Proceedings of the National Academy of Sciences. 104(21). 8947–8952. 243 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact